<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>05944756594374</udiDi>
    <basicUdiDi>B-05944756594374</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1594</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:12.032Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594367</udiDi>
    <basicUdiDi>B-05944756594367</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1593</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:11.232Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594350</udiDi>
    <basicUdiDi>B-05944756594350</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1592</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:10.441Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594343</udiDi>
    <basicUdiDi>B-05944756594343</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1591</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:09.630Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594336</udiDi>
    <basicUdiDi>B-05944756594336</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1590</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:05.640Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594329</udiDi>
    <basicUdiDi>B-05944756594329</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1589</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:04.839Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594312</udiDi>
    <basicUdiDi>B-05944756594312</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1588</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:04.038Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594305</udiDi>
    <basicUdiDi>B-05944756594305</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1587</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:51:03.231Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594299</udiDi>
    <basicUdiDi>B-05944756594299</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1586</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:59.226Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594282</udiDi>
    <basicUdiDi>B-05944756594282</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1585</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:58.429Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594275</udiDi>
    <basicUdiDi>B-05944756594275</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1584</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:57.628Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594268</udiDi>
    <basicUdiDi>B-05944756594268</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1583</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:56.828Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594251</udiDi>
    <basicUdiDi>B-05944756594251</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1582</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:52.826Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594237</udiDi>
    <basicUdiDi>B-05944756594237</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1580</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:52.026Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594220</udiDi>
    <basicUdiDi>B-05944756594220</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1579</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:51.223Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594244</udiDi>
    <basicUdiDi>B-05944756594244</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1581</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:50.421Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594213</udiDi>
    <basicUdiDi>B-05944756594213</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1578</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:46.527Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594206</udiDi>
    <basicUdiDi>B-05944756594206</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1577</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:32.744Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594190</udiDi>
    <basicUdiDi>B-05944756594190</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1576</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:31.148Z</lastUpdated>
  </row>
  <row>
    <udiDi>05944756594183</udiDi>
    <basicUdiDi>B-05944756594183</basicUdiDi>
    <tradeName>DACRIL 910</tradeName>
    <deviceName>DACRIL 910</deviceName>
    <manufacturerName>BIOSINTEX SRL</manufacturerName>
    <manufacturerSrn>RO-MF-000001463</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>H010101020203</emdnCode>
    <emdnDescription>POLYGLYCOLIC WITH LACTIC ACID MULTIFILAMENT WITHOUT NEEDLE</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>BX-PG 1575</reference>
    <placedOnMarketCountry>Romania</placedOnMarketCountry>
    <lastUpdated>2026-07-06T06:50:30.340Z</lastUpdated>
  </row>
</eudamedExport>